Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion type Assertion NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_head.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion description "[Patients with MTC in remission (n=24) or in persistence (n=18), RET gene mutations carriers (n=14), patients with nodular goiter (n=69), and healthy volunteers (n=16) were submitted to pentagastrin and Ca (25 mg/kg) tests.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_provenance.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion evidence source_evidence_literature NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_provenance.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion SIO_000772 22170709 NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_provenance.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion wasDerivedFrom befree-20140225 NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_provenance.
- NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_assertion wasGeneratedBy ECO_0000203 NP759377.RA2rePUDxK7FuGe04AWpmoZ3xWACbANdcbX5e7csDj7oU130_provenance.